Clinical Trial Update: A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01) [Phase 3]

View source ↗

Summary

An ongoing Phase 3 trial comparing BL-B01D1 to physician's choice chemotherapy in patients with recurrent or metastatic urothelial carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• BL-B01D1
• Chemotherapy of Physician's Choice

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Urothelial Carcinoma | Phase 3 | Status: RECRUITING